ICU Medical, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: 10.13%

ICU Medical, Inc. EBITDA Margin is 10.13% for the Trailing 12 Months (TTM) ending March 31, 2025, a -51.49% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • ICU Medical, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was 20.88%, a 74.03% change year over year.
  • ICU Medical, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was 12.00%, a -2.05% change year over year.
  • ICU Medical, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was 12.25%, a -22.69% change year over year.
  • ICU Medical, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was 15.84%, a 4.46% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin